Rafferty Asset Management, LLC Xeris Biopharma Holdings, Inc. Transaction History
Rafferty Asset Management, LLC
- $29.7 Billion
- Q3 2025
A detailed history of Rafferty Asset Management, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 17,411 shares of XERS stock, worth $126,229. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,411
Previous 25,903
32.78%
Holding current value
$126,229
Previous $120,000
17.5%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding XERS
# of Institutions
236Shares Held
94.1MCall Options Held
251KPut Options Held
61.8K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...